Loading clinical trials...
Loading clinical trials...
Primary Objective: To assess the long-term safety of GZ/SAR402671 in adult male participants with Fabry disease who previously completed study ACT13739 (NCT02489344). Secondary Objective: To assess...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genzyme, a Sanofi Company
NCT06941025 · Fabry Disease, Pregnancy, and more
NCT06328608 · Fabry Disease
NCT06539624 · Fabry Disease
NCT07382128 · HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, and more
NCT05923788 · Fabry Disease
Investigational Site Number 840002
Atlanta, Georgia
Investigational Site Number 840003
Cincinnati, Ohio
Investigational Site Number 840001
Fairfax, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions